Abstract: A ventilation assistance device and a method of using a ventilation assistance device for providing ventilation to a subject. The ventilation assistance device comprises a duct configured to be connectable between a source of gas and an interface device, for establishing fluid communication between the source of gas and the interface device for delivering gas to a subject's airway; a flow sensor configured to determine a flow volume of gas in the duct; and an operator interface configured to represent a measure of gas received by the subject by way of a plurality of indicators, each indicator being representative of the measure being within a particular range suitable for respective reference subjects having respective characteristics; wherein the operator interface is configured to display one of the plurality of indicators based on the flow volume determined by the flow sensor to represent to an operator the characteristic of the reference subject for which the gas received is suitable.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-dimethylaminomethyl-[1-3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-dimethylaminomethyl-[1-3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-dimethylaminomethyl-[1-3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-dimethylaminomethyl-[1-3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: A modular, portable, drive-through tire tread wear and brake testing system including a tire tread wear analyzer and flat plate brake tester housed in an intermodal cargo shipping container. Doors open on opposing sides of the container to permit a vehicle to be driven through it and, as the vehicle passes over the floor of the modular container and the flat plate brake tester, its tires are scanned by a flush-mounted tire tread depth scanner. The scanned output, a digitized tread profile, is analyzed for tread depth, tire wear patterns from chronic under- or over-inflation, and wheel misalignment. Cameras trained on the vehicle entering the container that feed video to monitors visible to the driver plus structural components on the floor of the container help to guide the vehicle into position over the scanner. The tire and brake report is generated immediately and transmitted to the appropriate recipient.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-Dilinoley 1-4-dimethylaminomethyl-[1,3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-Dilinoley 1-4-dimethylaminomethyl-[1,3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: The invention features a method of identifying therapeutically relevant compositions which include a therapeutic agent and 2,2-Dilinoley 1-4-dimethylaminomethyl-[1,3]-dioxolane by screening for an effect of the agent on the liver of a model subject.

Abstract: The invention features a method of identifying therapeutically relevant compositions that include a therapeutic agent and a delivery component by screening for an effect of the agent on the liver of a model subject.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: A method and apparatus for controlling a power supply. The system includes a power supply and a controller for outputting a command signal to regulate the operation of the power supply. The controller determines the command signal based on at least one error signal which is selected from a plurality of error signals based on a selection criterion.

Abstract: A computer comprising a biometric device communicatively coupled to operational electronics of the computer and the biometric device being physically coupled to a housing of the computer in a non-removable fashion, the biometric device having an operative surface for receiving biometric input. The computer further comprising a mechanism associated with the biometric device and configured to control movement of the operative surface between extended and retracted positions, wherein the extended position is characterized such that the operative surface is exposed for use and the retracted position is characterized such that the operative surface is not exposed for use.

Abstract: A heat-dissipating wireless communication system for a computer device comprises an antenna configured for wireless communications, the antenna configured to dissipate heat generated by the computer device.

Abstract: A device for distributing waste heat from a heat source evenly across an exterior surface of an enclosure is disclosed. The device includes a first layer of material that has a high thermal conductivity along a first plane. One or more layers of material that include a controlled thermal conductivity along a second plane are connected with the first layer. At least one of those layers has a low thermal conductivity (e.g. a thermal insulating material) in the second plane and that layer is positioned between the heat source and the enclosure so that heat flow through that layer is substantially inhibited in the second plane and a majority of the waste heat is thermally transferred through the first layer along the first plane to the exterior surface where the waste heat is uniformly distributed thereby reducing hot spots on the exterior surface which can cause user discomfort.